Cargando…
Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study
To reduce vaccine hesitancy, it is important to identify factors that can intervene at the individual or community level. Social capital is a possible factor because it is associated with various vaccine hesitancy, such as for measles and influenza. However, limited studies have explored the associa...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621029/ https://www.ncbi.nlm.nih.gov/pubmed/35708308 http://dx.doi.org/10.1080/21645515.2022.2086773 |
_version_ | 1784821448604385280 |
---|---|
author | Machida, Masaki Kikuchi, Hiroyuki Kojima, Takako Nakamura, Itaru Saito, Reiko Nakaya, Tomoki Hanibuchi, Tomoya Takamiya, Tomoko Odagiri, Yuko Fukushima, Noritoshi Amagasa, Shiho Watanabe, Hidehiro Inoue, Shigeru |
author_facet | Machida, Masaki Kikuchi, Hiroyuki Kojima, Takako Nakamura, Itaru Saito, Reiko Nakaya, Tomoki Hanibuchi, Tomoya Takamiya, Tomoko Odagiri, Yuko Fukushima, Noritoshi Amagasa, Shiho Watanabe, Hidehiro Inoue, Shigeru |
author_sort | Machida, Masaki |
collection | PubMed |
description | To reduce vaccine hesitancy, it is important to identify factors that can intervene at the individual or community level. Social capital is a possible factor because it is associated with various vaccine hesitancy, such as for measles and influenza. However, limited studies have explored the association between social capital and vaccination for COVID-19, which is an unprecedented pandemic and infodemic. Therefore, this study aimed to clarify the association between social capital and COVID-19 vaccination during the pandemic. This cross-sectional study used quota sampling for an online-based survey. Participants were asked whether they had previously been vaccinated for COVID-19 and their intention to receive a COVID-19 vaccine booster. Social capital was evaluated using three measures (individual-level civic participation, social cohesion, and reciprocity). Multiple logistic regression analysis was performed to clarify the association between social capital and previous COVID-19 vaccination status as well as intention to receive a COVID-19 booster. Participants were 2,313 individuals, of whom 87.2% had received a COVID-19 vaccine; 72.3% intended to obtain a COVID-19 booster. Individuals with any social capital are more likely to receive a COVID-19 vaccination than those with none (OR: 1.73, 95%CI: 1.18–2.54; OR: 1.58, 95%CI: 1.22–2.05; OR: 3.05, 95%CI: 2.15–4.33). These indicators were also associated with the intention to receive a COVID-19 booster. Thus, our results suggest that among the general public, those with individual-level social capital are more likely to receive a COVID-19 vaccination than those with none. Social capital may be a factor that can reduce vaccine hesitancy during a pandemic. |
format | Online Article Text |
id | pubmed-9621029 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-96210292022-11-01 Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study Machida, Masaki Kikuchi, Hiroyuki Kojima, Takako Nakamura, Itaru Saito, Reiko Nakaya, Tomoki Hanibuchi, Tomoya Takamiya, Tomoko Odagiri, Yuko Fukushima, Noritoshi Amagasa, Shiho Watanabe, Hidehiro Inoue, Shigeru Hum Vaccin Immunother Coronavirus – Research Paper To reduce vaccine hesitancy, it is important to identify factors that can intervene at the individual or community level. Social capital is a possible factor because it is associated with various vaccine hesitancy, such as for measles and influenza. However, limited studies have explored the association between social capital and vaccination for COVID-19, which is an unprecedented pandemic and infodemic. Therefore, this study aimed to clarify the association between social capital and COVID-19 vaccination during the pandemic. This cross-sectional study used quota sampling for an online-based survey. Participants were asked whether they had previously been vaccinated for COVID-19 and their intention to receive a COVID-19 vaccine booster. Social capital was evaluated using three measures (individual-level civic participation, social cohesion, and reciprocity). Multiple logistic regression analysis was performed to clarify the association between social capital and previous COVID-19 vaccination status as well as intention to receive a COVID-19 booster. Participants were 2,313 individuals, of whom 87.2% had received a COVID-19 vaccine; 72.3% intended to obtain a COVID-19 booster. Individuals with any social capital are more likely to receive a COVID-19 vaccination than those with none (OR: 1.73, 95%CI: 1.18–2.54; OR: 1.58, 95%CI: 1.22–2.05; OR: 3.05, 95%CI: 2.15–4.33). These indicators were also associated with the intention to receive a COVID-19 booster. Thus, our results suggest that among the general public, those with individual-level social capital are more likely to receive a COVID-19 vaccination than those with none. Social capital may be a factor that can reduce vaccine hesitancy during a pandemic. Taylor & Francis 2022-06-16 /pmc/articles/PMC9621029/ /pubmed/35708308 http://dx.doi.org/10.1080/21645515.2022.2086773 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Coronavirus – Research Paper Machida, Masaki Kikuchi, Hiroyuki Kojima, Takako Nakamura, Itaru Saito, Reiko Nakaya, Tomoki Hanibuchi, Tomoya Takamiya, Tomoko Odagiri, Yuko Fukushima, Noritoshi Amagasa, Shiho Watanabe, Hidehiro Inoue, Shigeru Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study |
title | Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study |
title_full | Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study |
title_fullStr | Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study |
title_full_unstemmed | Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study |
title_short | Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study |
title_sort | individual-level social capital and covid-19 vaccine hesitancy in japan: a cross-sectional study |
topic | Coronavirus – Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621029/ https://www.ncbi.nlm.nih.gov/pubmed/35708308 http://dx.doi.org/10.1080/21645515.2022.2086773 |
work_keys_str_mv | AT machidamasaki individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT kikuchihiroyuki individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT kojimatakako individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT nakamuraitaru individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT saitoreiko individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT nakayatomoki individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT hanibuchitomoya individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT takamiyatomoko individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT odagiriyuko individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT fukushimanoritoshi individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT amagasashiho individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT watanabehidehiro individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT inoueshigeru individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy |